These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26832969)

  • 1. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification.
    Kwon DH; Eom GH; Ko JH; Shin S; Joung H; Choe N; Nam YS; Min HK; Kook T; Yoon S; Kang W; Kim YS; Kim HS; Choi H; Koh JT; Kim N; Ahn Y; Cho HJ; Lee IK; Park DH; Suk K; Seo SB; Wissing ER; Mendrysa SM; Nam KI; Kook H
    Nat Commun; 2016 Feb; 7():10492. PubMed ID: 26832969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC1-mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure.
    Zhou J; Zhou H; Liu C; Huang L; Lu D; Gao C
    J Cell Mol Med; 2020 Aug; 24(15):8636-8649. PubMed ID: 32596952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1.
    Xiang HL; Yuan Q; Zeng JY; Xu ZY; Zhang HZ; Huang J; Song AN; Xiong J; Zhang C
    Acta Pharmacol Sin; 2024 Nov; 45(11):2328-2338. PubMed ID: 38760541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MDM2 E3 ligase-dependent vascular calcification by MSX1/2.
    Kwon DH; Choe N; Shin S; Ryu J; Kim N; Eom GH; Nam KI; Kim HS; Ahn Y; Kim YK; Park WJ; Mendrysa SM; Kook H
    Exp Mol Med; 2021 Nov; 53(11):1781-1791. PubMed ID: 34845330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Aspects of Vascular Calcification: Histone Deacetylases and Beyond.
    Kwon DH; Kim YK; Kook H
    J Korean Med Sci; 2017 Nov; 32(11):1738-1748. PubMed ID: 28960024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.
    Bonacci T; Audebert S; Camoin L; Baudelet E; Iovanna JL; Soubeyran P
    PLoS One; 2017; 12(1):e0169988. PubMed ID: 28099510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) inhibits vascular calcification in rats.
    Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
    Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities.
    Kass EM; Poyurovsky MV; Zhu Y; Prives C
    Cell Cycle; 2009 Feb; 8(3):430-7. PubMed ID: 19176998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ligase MDM2 mediates urea transporter-A1 ubiquitination under either constitutive or stimulatory conditions.
    Su H; Ye C; Sands JM; Zhang C
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1331-F1341. PubMed ID: 31509007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
    Shen H; Zhang J; Wang C; Jain PP; Xiong M; Shi X; Lei Y; Chen S; Yin Q; Thistlethwaite PA; Wang J; Gong K; Yuan ZY; Yuan JX; Shyy JY
    Circulation; 2020 Sep; 142(12):1190-1204. PubMed ID: 32755395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
    Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
    Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
    Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
    Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.